Trade

with

Biocept Inc
(NASDAQ: BIOC)
AdChoices
2.81
-0.03
-1.06%
After Hours :
2.81
0.00
0.00%

Open

2.77

Previous Close

2.84

Volume (Avg)

10.30k (20.95k)

Day's Range

2.75-2.92

52Wk Range

2.27-10.02

Market Cap.

12.50M

Dividend Rate ( Yield )

-

Beta

-

Shares Outstanding

4.45M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 134.24k

    • Net Income

    • -9.23M

    • Market Cap.

    • 12.50M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -13,697.72

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -

    • Forward P/E

    • -

    • Price/Sales

    • 53.76

    • Price/Book Value

    • 1.84

    • Price/Cash flow

    • -0.48

      • EBITDA

      • -6.90M

      • Return on Capital %

      • -187.53

      • Return on Equity %

      • -

      • Return on Assets %

      • -187.53

      • Book Value/Share

      • 1.55

      • Shares Outstanding

      • 4.45M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 16.00

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -60.20

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -

          • -5.55

          • Net Income

            Q/Q (last year)

          • -

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 47.82

          • Net Income

            5-Year Annual Average

          • -

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -2,146.59

            • 42.70

            • Pre-Tax Margin

            • -13,696.90

            • 11.63

            • Net Profit Margin

            • -13,697.72

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.68

              • 0.62

              • Current Ratio

              • 10.20

              • 1.23

              • Quick Ratio

              • 9.81

              • 0.76

              • Interest Coverage

              • -

              • 5.98

              • Leverage Ratio

              • 1.94

              • 2.16

              • Book Value/Share

              • 1.55

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -0.39

                • 32.79

                • P/E Ratio 5-Year High

                • -1.39

                • 325.07

                • P/E Ratio 5-Year Low

                • -0.31

                • 154.73

                • Price/Sales Ratio

                • 53.76

                • 2.30

                • Price/Book Value

                • 1.84

                • 2.98

                • Price/Cash Flow Ratio

                • -0.48

                • 18.76

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -

                    (-)

                  • 9.34

                    (9.80)

                  • Return on Assets %

                    (5-Year Average)

                  • -187.53

                    (-)

                  • 4.63

                    (5.44)

                  • Return on Capital %

                    (5-Year Average)

                  • -

                    (-)

                  • 5.73

                    (6.77)

                  • Income/Employee

                  • -

                  • 17.17k

                  • Inventory Turnover

                  • 19.69

                  • 5.07

                  • Asset Turnover

                  • 0.01

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -7.94M
                  Operating Margin
                  -5,917.86
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -0.48
                  Ownership

                  Institutional Ownership

                  9.57%

                  Top 10 Institutions

                  9.56%

                  Mutual Fund Ownership

                  0.66%

                  Float

                  48.54%

                  5% / Insider Ownership

                  0.35%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Total Stock Mkt Idx

                  •  

                    29,465

                  • 0.00

                  • 0.66

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Garrison Bradford & Associates Inc

                  •  

                    153,400

                  • -1.92%

                  • 3.45

                  • Perkins Capital Management Inc

                  •  

                    115,950

                  • +29.63%

                  • 2.61

                  • Verition Fund Managegment, LLC

                  •  

                    82,746

                  • +2.81%

                  • 1.86

                  • Vanguard Group, Inc.

                  •  

                    29,465

                  • +5.74%

                  • 0.66

                  • LMR Partners LLP

                  •  

                    29,398

                  • -32.96%

                  • 0.66

                  • UBS Securities LLC

                  •  

                    2,225

                  • +214.71%

                  • 0.05

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Diagnostics & Research

                  Type

                  Speculative Growth

                  Style

                  -

                  Biocept Inc is a commercial-stage cancer diagnostics company developing and commercializing proprietary circulating tumor cell (CTC) and circulating tumor DNA (ctDNA) tests utilizing a standard blood sample.

                  Key People

                  Mr. Michael W. Nall

                  Director/CEO/President

                  David F. Hale

                  Chairman of the Board/Director

                  William G. Kachioff

                  CFO/Chief Accounting Officer/Senior VP, Divisional

                  Mr. Bruce E. Gerhardt

                  Director

                  Mr. Edward Neff

                  Director

                  • Biocept Inc

                  • 5810 Nancy Ridge Drive

                  • San Diego, CA 92121

                  • USA.Map

                  • Phone: +1 858 320-8200

                  • Fax: +1 877 300-1761

                  • biocept.com

                  Incorporated

                  1997

                  Employees

                  28

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: